According to a study recently published in the British Journal of Ophthalmology from Kochi Medical School in Japan, “tacrolimus eye drops are highly effective in treating allergic conjunctivitis with proliferative lesions and/or corneal involvement, and may reduce or replace topical steroid use.”

More than 300 optometrists and students recently visited every U.S. Senator and House member in Washington, DC for the American Optometric Association’s 2014 Congressional Advocacy Conference in an effort to bring attention to optometry’s top priorities.

According to several presentations given during the American Society of Cataracts and Refractive Surgery 2014 meeting, the investigational Raindrop (ReVision Optics) transparent hydrogel corneal inlay has shown to be consistently effective for the correction of presbyopia, is relatively easy to implant, and has high patient satisfaction.

Shire recently announced its plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lifitegrast for the treatment of dry eye disease in adults in first-quarter 2015.

The Lousisiana Legislature passed a bill last week that makes the state the third in the nation to allow optometrists to perform certain surgeries. The bill has gone on to Governor Bobby Jindal for his signature.

A recent study found that metformin (Glumetza, Salix), a popular diabetes drug, is associated with a dose-dependent risk reduction for open-angle glaucoma.

The American Academy of Ophthalmology recently released results of a poll that found the majority of Americans are unaware of the increased risks to ultraviolet (UV) light exposure that are linked to common drugs and having light-colored eyes.

Medscape has released its third-annual list of the best and worst big cities and small towns in the United States to practice, based on lifestyle, climate, practice conditions, and amenities. So did your city make the list?

The Association of Schools and Colleges of Optometry (ASCO) has received the Focus Grant from the Allergan Foundation to support ASCO’s “Be a Doctor of Optometry: Put Your Future in Focus” video.

Kansas and Vermont’s legislatures have both recently passed bills, which restrict the leeway managed vision care plans have in contracts with optometrists.

New York is one of the two states that have yet to allow optometrists to prescribe certain oral medications, but the state’s ODs are looking to change that.

Two reports from Optos Peripheral Retina studies, which are ancillary studies for Age-Related Eye Disease Study 2 (AREDS2), were presented last week at ARVO.

During the Association for Research in Vision and Ophthalmology meeting last week, Eleven Biotherapeutics presented data for 2 of its protein therapeutics, which demonstrate the role of cytokine biology to target both anterior and posterior eye diseases.

The results of 2 clinical studies on latanosprostene bunod-CONSTELLATION and KRONUS- were presented during the Association for Research in Vision and Ophthalmology meeting last week.

This week, Allergan’s board of directors unanimously rejected an unsolicited proposal from Valeant Pharmaceuticals International, Inc.

In an effort to reduce the wait time for access to eye care, the Canadian province of Alberta has expanded the scope of practice for optometrists.

The American Optometric Association’s Contact Lens and Cornea Section (CLCS) has released the Anterior Segment Image Catalog.

The Association for Research in Vision and Ophthalmology held its annual conference in Orlando, FL, last week and Optometry Times’ sister publication, Ophthalmology Times, was there to catch up on the latest research on glaucoma, AMD, and other diseases.

A year-long study of 1-Day Acuvue TruEye and 1-Day Acuvue Moist brands designed to observe “real-life” contact lens wear found that subjects who wore 1-Day Acuvue Moist reported low incidence of adverse events.

During the ARVO meeting last week, Bausch + Lomb researchers presented results from the 5th Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study in the United States, as well as the first data from the study in Canada.